TY - JOUR
T1 - Acceptability of self-sample human papillomavirus testing among medically underserved women visiting the emergency department
AU - Montealegre, Jane R.
AU - Landgren, Rachel M.
AU - Anderson, Matthew L.
AU - Hoxhaj, Shkelzen
AU - Williams, Sandra
AU - Robinson, David J.
AU - Scheurer, Michael E.
AU - Ramondetta, Lois M.
N1 - Publisher Copyright:
© 2015 Elsevier Inc. All rights reserved.
PY - 2015/8/1
Y1 - 2015/8/1
N2 - Objective Self-sample human papillomavirus (HPV) testing in public emergency departments (EDs) may be a viable strategy to opportunistically screen women who otherwise do not attend for regular Papanicolaou test-based cervical cancer screening. We describe the acceptability of self-sample HPV testing among women presenting to two high-volume, urban EDs that primarily care for the medically underserved. Methods In 2014, a total of 210 women 21 years of age and older were recruited from two public ED waiting areas following a two-stage cluster sampling design. Questionnaire items inquired about demographics, healthcare access and utilization, history of cervical cancer screening, and acceptability of self-sample HPV testing. Descriptive analyses were performed. Results Overall, 34.8% of participants were considered screening non-attendees based on their adherence to the current guidelines for Pap testing every three years. Acceptability of self-sample HPV testing was high, with over 85% of participants reporting that they would be willing to use the test if available. A smaller proportion (58%) was deemed likely to accept self-sample HPV testing in a public ED restroom setting. Primary concerns expressed by women were that the sampling may not be done correctly (64%) and that they may not know how to perform the sampling (39%). Conclusions Opportunistic self-sample HPV testing is acceptable to women seeking care at a high-volume, urban emergency care center. The use of this intervention potentially offers a unique strategy to improve cervical cancer screening among high-risk women who otherwise do not attend for regular screening.
AB - Objective Self-sample human papillomavirus (HPV) testing in public emergency departments (EDs) may be a viable strategy to opportunistically screen women who otherwise do not attend for regular Papanicolaou test-based cervical cancer screening. We describe the acceptability of self-sample HPV testing among women presenting to two high-volume, urban EDs that primarily care for the medically underserved. Methods In 2014, a total of 210 women 21 years of age and older were recruited from two public ED waiting areas following a two-stage cluster sampling design. Questionnaire items inquired about demographics, healthcare access and utilization, history of cervical cancer screening, and acceptability of self-sample HPV testing. Descriptive analyses were performed. Results Overall, 34.8% of participants were considered screening non-attendees based on their adherence to the current guidelines for Pap testing every three years. Acceptability of self-sample HPV testing was high, with over 85% of participants reporting that they would be willing to use the test if available. A smaller proportion (58%) was deemed likely to accept self-sample HPV testing in a public ED restroom setting. Primary concerns expressed by women were that the sampling may not be done correctly (64%) and that they may not know how to perform the sampling (39%). Conclusions Opportunistic self-sample HPV testing is acceptable to women seeking care at a high-volume, urban emergency care center. The use of this intervention potentially offers a unique strategy to improve cervical cancer screening among high-risk women who otherwise do not attend for regular screening.
KW - Cervical cancer screening
KW - Emergency departments
KW - Human papillomavirus
KW - Self-testing
UR - http://www.scopus.com/inward/record.url?scp=84938202634&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84938202634&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2015.05.028
DO - 10.1016/j.ygyno.2015.05.028
M3 - Article
C2 - 26026733
AN - SCOPUS:84938202634
SN - 0090-8258
VL - 138
SP - 317
EP - 322
JO - Gynecologic oncology
JF - Gynecologic oncology
IS - 2
ER -